Search
Now showing items 1-1 of 1
Modulating Glycogen Synthase Kinase-3 in Chronic Lymphocytic Leukemia
(2015-07-31)
Chronic lymphocytic leukemia (CLL) is the most common hematological malignancy in North
America and Europe with a median age of onset of 72. Due to the advanced age of most
patients with CLL, many are unable to tolerate ...